If you’ve been researching fertility after 35, you’ve likely encountered the term AMH — anti-Müllerian hormone. It shows up in conversations, lab panels, and online forums with a kind of outsized weight, as though a single number can capture everything meaningful about fertility. The reality, research suggests, is considerably more nuanced than that.
AMH is a hormone produced by the small follicles in the ovaries, and it’s widely used as an indicator of ovarian reserve — roughly, how many eggs may be available. Understanding what AMH actually measures, what it doesn’t measure, and how it changes after 35 can help put your own results in helpful context.
This article explores what current research says about AMH levels in women over 35, including why the numbers don’t tell the whole story and what conversations with a healthcare provider might look like.
What AMH Actually Measures
AMH is secreted by the granulosa cells surrounding small antral follicles in the ovaries. Because these follicles reflect the current pool of developing eggs, AMH gives clinicians a window into what researchers call “ovarian reserve” — the estimated quantity of remaining eggs.
It’s worth being precise about what this does and doesn’t mean. AMH reflects quantity, not quality. Two women with identical AMH levels may have very different fertility experiences, and individual variation is considerable. Research published in the journal Fertility and Sterility via NIH has confirmed that while AMH correlates with ovarian reserve, it does not reliably predict whether any individual will conceive naturally.
This distinction matters. AMH was originally developed as a tool for predicting response to ovarian stimulation in IVF protocols — a context where it performs well. Its use as a standalone predictor of natural fertility is considerably more limited, and clinicians increasingly acknowledge this nuance.
How AMH Changes After 35
AMH levels generally decline with age, beginning well before menopause. Research indicates that this decline is gradual rather than sudden, though the rate of change varies among individuals.
Studies have found that AMH begins declining measurably in a woman’s early 30s and continues declining through perimenopause. By the mid-40s, levels are often very low or undetectable. However, individual trajectories differ significantly — some women in their late 30s maintain AMH levels in ranges typically seen in younger women, while others experience steeper declines earlier.
After 35, several factors may influence where your AMH falls relative to population averages:
- Genetic factors: Family history of early menopause is associated with lower AMH at younger ages
- Previous ovarian surgery: Procedures such as cystectomy for endometrioma may reduce ovarian reserve
- Autoimmune conditions: Some autoimmune disorders are associated with diminished ovarian reserve
- Smoking history: Research suggests smoking is associated with lower AMH levels
- Body weight: AMH levels may vary with BMI, though the relationship is complex
It’s important to frame these associations carefully: they describe population-level patterns, not individual destinies. If your AMH falls below what a lab report marks as “normal for age,” that context matters — but it doesn’t determine your outcome. For more on understanding fertility changes and what to expect after 35, the research picture is reassuring in many respects.
Interpreting Your Results: What the Numbers Mean in Practice
Reference ranges for AMH vary by laboratory and by which assay is used, which can make comparing numbers across different tests tricky. A result that one lab flags as “low” may fall within the reference range of another lab’s assay.
Generally speaking, clinicians consider AMH in context rather than in isolation. A complete fertility workup typically includes:
- AMH testing
- Antral follicle count (AFC) via transvaginal ultrasound
- Day 2-3 FSH and estradiol levels
- Assessment of menstrual cycle regularity
- Partner fertility evaluation when applicable
A lower-than-average AMH combined with a low antral follicle count and elevated FSH gives a more complete picture than AMH alone. Conversely, a single low AMH result without other indicators of reduced reserve may prompt further testing rather than conclusions.
If you’ve received an AMH result that concerns you, a reproductive endocrinologist can help interpret it within the context of your full clinical picture. For information about when to see a fertility specialist, understanding the timing and framing of that conversation can make it more productive.
What AMH Doesn’t Tell You About Your Fertility
Perhaps the most important thing to understand about AMH is what it doesn’t predict. Studies have consistently found that AMH does not reliably predict time to natural conception among women who are actively trying to get pregnant.
A notable study published in JAMA found that among women aged 30-44 trying to conceive naturally, those with low AMH were no less likely to conceive within a year than women with normal AMH levels. While this study has nuances and is not the final word on the topic, it illustrates that the relationship between AMH and natural fertility is far from straightforward.
AMH also says nothing about:
- Egg quality or chromosomal integrity
- Uterine receptivity
- Fallopian tube function
- The fertility of a partner, if applicable
- Hormonal patterns across the cycle
For all these reasons, many fertility specialists describe AMH as one data point in a larger picture — useful in the right clinical context, but easily misinterpreted when viewed in isolation.
Having a Productive Conversation with Your Provider
If you’ve had AMH testing done — or are considering it — there are several questions that may help frame the conversation with your healthcare provider:
- What does this result mean in the context of my other fertility markers?
- Does this change your recommendations for timing or approach?
- What follow-up testing, if any, would help complete this picture?
- How does my AMH relate to my options if I’m also considering assisted reproduction?
It’s worth knowing that a low AMH result is not necessarily a reason to panic or rush — though it may be a reason to have timely conversations with a reproductive specialist. Individual outcomes vary considerably, and many women with below-average AMH conceive naturally or respond well to fertility treatment.
Frequently Asked Questions
Can AMH levels improve over time?
Research on this question is ongoing. Unlike some hormones, AMH is thought to reflect the underlying pool of primordial follicles, which doesn’t replenish. Some studies have suggested small variations with lifestyle changes or supplementation, but the evidence for meaningful clinical change is not well established. Discussing this question with a reproductive endocrinologist can offer the most current guidance.
Should everyone over 35 get an AMH test?
There is no universal recommendation for routine AMH testing in women without fertility concerns. However, for women over 35 who are planning to conceive or exploring their options, testing may provide useful context. A healthcare provider can help determine whether AMH testing is appropriate for your individual situation.
What’s considered a “normal” AMH after 35?
Reference ranges vary by laboratory and age, and what’s considered “normal” shifts with each decade. Rather than comparing your result to a general range, it’s most helpful to discuss it with a clinician who can interpret it alongside your antral follicle count, FSH, and clinical history. Numbers without context have limited meaning.
Does a low AMH mean I should pursue IVF immediately?
Not necessarily. A low AMH may prompt earlier evaluation and conversation about timelines, but it doesn’t automatically indicate that IVF is the right or only path. The decision about fertility treatment involves many factors beyond AMH, including your overall health, relationship circumstances, personal values, and a full fertility workup. A reproductive endocrinologist can help you understand your specific options.
Key Takeaways
- AMH is a marker of ovarian reserve (quantity), not egg quality or overall fertility potential
- AMH levels decline with age, but individual variation is significant — one number doesn’t define your fertility
- Research suggests AMH does not reliably predict natural conception rates in women actively trying to conceive
- AMH is most useful as one part of a comprehensive fertility evaluation, not as a standalone test
- If your AMH result concerns you, a reproductive endocrinologist can provide personalized interpretation and next steps
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.